SHSE:688016 (China)
Â
Class A
Â¥
91.63
-1.52 (-1.63%)
Aug 5
Business Description
Shanghai MicroPort Endovascular MedTech (Group) Co Ltd
ISIN : CNE100003MJ5
Share Class Description:
SHSE:688016: Class ATotal Employee Number:
822Compare
Compare
Traded in other countries / regions
688016.China Index Membership
SSE Composite Index IPO Date
2019-07-22Description
Shanghai MicroPort Endovascular MedTech (Group) Co Ltd is engaged in the research and development (R&D), manufacturing, sales and services of aortic, peripheral vascular and tumor intervention devices. Its product portfolio includes thoracic and abdominal aortic stent grafts, peripheral vascular stents, drug-coated balloon dilatation catheters, balloon dilatation catheters, vena cava filters, snare retrieval kits, thrombectomy devices, and tumor embolization microspheres. The company markets its products in China and international markets, including Europe, Latin America, Asia, and Africa.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 172.55 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-EBITDA | 0.02 | |||||
Interest Coverage | 506.09 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 14.33 | |||||
Beneish M-Score | -2.24 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.1 | |||||
3-Year EBITDA Growth Rate | 13.1 | |||||
3-Year EPS without NRI Growth Rate | 11.1 | |||||
3-Year FCF Growth Rate | 81.8 | |||||
3-Year Book Growth Rate | 27.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 16.11 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 18.61 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 55.47 | |||||
9-Day RSI | 54.69 | |||||
14-Day RSI | 52.53 | |||||
3-1 Month Momentum % | -8.42 | |||||
6-1 Month Momentum % | -5.59 | |||||
12-1 Month Momentum % | -16.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.94 | |||||
Quick Ratio | 6.27 | |||||
Cash Ratio | 4.9 | |||||
Days Inventory | 234.43 | |||||
Days Sales Outstanding | 104.66 | |||||
Days Payable | 49.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.5 | |||||
Dividend Payout Ratio | 0.33 | |||||
3-Year Dividend Growth Rate | 5.4 | |||||
Forward Dividend Yield % | 2.5 | |||||
5-Year Yield-on-Cost % | 14.23 | |||||
3-Year Average Share Buyback Ratio | -4.7 | |||||
Shareholder Yield % | 2.87 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 71.98 | |||||
Operating Margin % | 49.27 | |||||
Net Margin % | 42.38 | |||||
EBITDA Margin % | 49.24 | |||||
FCF Margin % | 22.46 | |||||
OCF Margin % | 39.15 | |||||
ROE % | 14.62 | |||||
ROA % | 12.66 | |||||
ROIC % | 27.5 | |||||
3-Year ROIIC % | 15.82 | |||||
ROC (Joel Greenblatt) % | 78.87 | |||||
ROCE % | 16.35 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 18.78 | |||||
Forward PE Ratio | 15.36 | |||||
PE Ratio without NRI | 18.34 | |||||
Shiller PE Ratio | 27.27 | |||||
Price-to-Owner-Earnings | 27.38 | |||||
PEG Ratio | 0.89 | |||||
PS Ratio | 7.99 | |||||
PB Ratio | 2.68 | |||||
Price-to-Tangible-Book | 3.57 | |||||
Price-to-Free-Cash-Flow | 36.27 | |||||
Price-to-Operating-Cash-Flow | 20.54 | |||||
EV-to-EBIT | 13.6 | |||||
EV-to-EBITDA | 13.6 | |||||
EV-to-Revenue | 6.7 | |||||
EV-to-FCF | 29.82 | |||||
Price-to-GF-Value | 0.76 | |||||
Price-to-Projected-FCF | 1.79 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.4 | |||||
Price-to-Graham-Number | 1.73 | |||||
| Price-to-Net-Current-Asset-Value | 4.83 | |||||
| Price-to-Net-Cash | 7.61 | |||||
Earnings Yield (Greenblatt) % | 7.35 | |||||
FCF Yield % | 2.76 | |||||
Forward Rate of Return (Yacktman) % | 15.28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai MicroPort Endovascular MedTech (Group) Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,388.679 | ||
| EPS (TTM) (Â¥) | 4.88 | ||
| Beta | 1.4049 | ||
| 3-Year Sharpe Ratio | -0.18 | ||
| 3-Year Sortino Ratio | -0.27 | ||
| Volatility % | 19.99 | ||
| 14-Day RSI | 52.53 | ||
| 14-Day ATR (Â¥) | 2.754215 | ||
| 20-Day SMA (Â¥) | 91.8715 | ||
| 12-1 Month Momentum % | -16.26 | ||
| 52-Week Range (Â¥) | 83.33 - 124.3 | ||
| Shares Outstanding (Mil) | 123.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai MicroPort Endovascular MedTech (Group) Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai MicroPort Endovascular MedTech (Group) Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 1.000000 Cash Dividend | 2026-06-05 | 99.29 (-2.68%) | ||
| CNY 1.300000 Cash Dividend | 2025-10-17 | 105.28 (-0.69%) | ||
| CNY 0.350000 Cash Dividend | 2025-06-06 | 88.80 (-1.18%) | ||
| CNY 1.662050 Cash Dividend | 2024-11-08 | 105.68 (+3.91%) | ||
| 1.49:1 Stock Split | 2024-05-14 | 123.83 (-1.86%) |
Show
Entries
Shanghai MicroPort Endovascular MedTech (Group) Co Ltd Frequently Asked Questions
What is Shanghai MicroPort Endovascular MedTech (Group) Co Ltd(SHSE:688016)'s stock price today?
The current price of SHSE:688016 is ¥91.63. The 52 week high of SHSE:688016 is ¥124.30 and 52 week low is ¥83.33.
When is next earnings date of Shanghai MicroPort Endovascular MedTech (Group) Co Ltd(SHSE:688016)?
The next earnings date of Shanghai MicroPort Endovascular MedTech (Group) Co Ltd(SHSE:688016) is .
Does Shanghai MicroPort Endovascular MedTech (Group) Co Ltd(SHSE:688016) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai MicroPort Endovascular MedTech (Group) Co Ltd(SHSE:688016) is 2.5% (As of Today), Highest Dividend Payout Ratio of Shanghai MicroPort Endovascular MedTech (Group) Co Ltd(SHSE:688016) was 1.14. The lowest was 0.22. And the median was 0.38. The  Forward Dividend Yield % of Shanghai MicroPort Endovascular MedTech (Group) Co Ltd(SHSE:688016) is 2.5%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Shanghai MicroPort Endovascular MedTech (Group) Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers